# Treatment relations (informational, not axioms)
# Express which substances treat which disorders
# Used for suggesting therapies, not formal safety constraints

relation_type: treats

relations:
  # Diabetes treatments
  - source_id: metformin
    target_id: diabetes_mellitus_type_2
    strength: strong
    evidence: "First-line therapy for T2DM per ADA guidelines"

  - source_id: insulin
    target_id: diabetes_mellitus
    strength: strong
    evidence: "Indicated for all types of diabetes"

  - source_id: insulin
    target_id: diabetes_mellitus_type_2
    strength: strong
    evidence: "Used when oral agents insufficient or contraindicated"

  - source_id: insulin
    target_id: gestational_diabetes
    strength: strong
    evidence: "Preferred treatment when oral agents insufficient"

  - source_id: glyburide
    target_id: diabetes_mellitus_type_2
    strength: moderate
    evidence: "Second-line oral agent for T2DM"

  - source_id: glipizide
    target_id: diabetes_mellitus_type_2
    strength: moderate
    evidence: "Second-line oral agent for T2DM"

  # Hypertension treatments
  - source_id: lisinopril
    target_id: hypertension
    strength: strong
    evidence: "First-line antihypertensive"

  - source_id: amlodipine
    target_id: hypertension
    strength: strong
    evidence: "First-line antihypertensive"

  - source_id: losartan
    target_id: hypertension
    strength: strong
    evidence: "First-line antihypertensive"

  - source_id: methyldopa
    target_id: hypertension
    strength: moderate
    evidence: "Preferred in pregnancy-related hypertension"

  - source_id: labetalol
    target_id: hypertension
    strength: moderate
    evidence: "Preferred in pregnancy-related hypertension"

  - source_id: labetalol
    target_id: preeclampsia
    strength: strong
    evidence: "First-line for acute blood pressure control in preeclampsia"

  - source_id: nifedipine
    target_id: hypertension
    strength: moderate
    evidence: "Calcium channel blocker; safe in pregnancy"

  # HIV treatments
  - source_id: tenofovir
    target_id: hiv_infection
    strength: strong
    evidence: "Component of first-line ART regimens"

  - source_id: dolutegravir
    target_id: hiv_infection
    strength: strong
    evidence: "Preferred integrase inhibitor in first-line ART"

  - source_id: efavirenz
    target_id: hiv_infection
    strength: strong
    evidence: "NNRTI used in first-line ART regimens"

  - source_id: emtricitabine
    target_id: hiv_infection
    strength: strong
    evidence: "NRTI backbone in combination ART"

  # Diabetes Type 1 treatments
  - source_id: insulin
    target_id: diabetes_mellitus_type_1
    strength: strong
    evidence: "Required for glucose control in T1DM"

  - source_id: insulin_glargine
    target_id: diabetes_mellitus_type_1
    strength: strong
    evidence: "Long-acting basal insulin for T1DM"

  # Additional hypertension treatment
  - source_id: enalapril
    target_id: hypertension
    strength: strong
    evidence: "ACE inhibitor for blood pressure control"

  # Asthma treatments
  - source_id: albuterol
    target_id: asthma
    strength: strong
    evidence: "Reliever medication for acute bronchospasm"

  - source_id: budesonide
    target_id: asthma
    strength: strong
    evidence: "Controller medication for chronic asthma management"

  # COPD treatments
  - source_id: albuterol
    target_id: copd
    strength: strong
    evidence: "Bronchodilator for symptom relief"

  - source_id: tiotropium
    target_id: copd
    strength: strong
    evidence: "Long-acting bronchodilator for COPD maintenance"

  - source_id: budesonide
    target_id: copd
    strength: moderate
    evidence: "Used in combination therapy for severe COPD"

  # Atrial fibrillation treatments
  - source_id: warfarin
    target_id: atrial_fibrillation
    strength: strong
    evidence: "Anticoagulation for stroke prevention in AFib"

  - source_id: apixaban
    target_id: atrial_fibrillation
    strength: strong
    evidence: "DOAC for stroke prevention in AFib; fewer monitoring requirements"

  - source_id: metoprolol
    target_id: atrial_fibrillation
    strength: strong
    evidence: "Beta blocker for rate control in AFib"

  # Coronary artery disease treatments
  - source_id: aspirin
    target_id: coronary_artery_disease
    strength: strong
    evidence: "Antiplatelet therapy for secondary prevention"

  - source_id: clopidogrel
    target_id: coronary_artery_disease
    strength: strong
    evidence: "Antiplatelet therapy, often used with aspirin (DAPT)"

  - source_id: atorvastatin
    target_id: coronary_artery_disease
    strength: strong
    evidence: "Statin for lipid management and plaque stabilization"

  - source_id: metoprolol
    target_id: coronary_artery_disease
    strength: strong
    evidence: "Beta blocker for angina and post-MI management"

  # Stroke treatments (secondary prevention)
  - source_id: aspirin
    target_id: stroke
    strength: strong
    evidence: "Antiplatelet therapy for secondary stroke prevention"

  - source_id: clopidogrel
    target_id: stroke
    strength: strong
    evidence: "Alternative antiplatelet for stroke prevention"

  - source_id: apixaban
    target_id: stroke
    strength: strong
    evidence: "Anticoagulation for cardioembolic stroke prevention"

  - source_id: atorvastatin
    target_id: stroke
    strength: strong
    evidence: "Statin for lipid management and stroke risk reduction"

  # Hypothyroidism treatment
  - source_id: levothyroxine
    target_id: hypothyroidism
    strength: strong
    evidence: "Thyroid hormone replacement therapy"

  # Major depressive disorder treatments
  - source_id: sertraline
    target_id: depression
    strength: strong
    evidence: "First-line SSRI for depression"

  - source_id: fluoxetine
    target_id: depression
    strength: strong
    evidence: "First-line SSRI for depression"

  # Tuberculosis treatments
  - source_id: rifampin
    target_id: tuberculosis
    strength: strong
    evidence: "Core component of standard TB treatment regimen"

  - source_id: isoniazid
    target_id: tuberculosis
    strength: strong
    evidence: "Core component of standard TB treatment regimen"
